Familial Short Stature (FSS) Latest Advances

The Reassuring and Misleading Myth of Familial Short Stature.

Journal: JAMA pediatrics

Published: July 07, 2025

Two cases of autosomal dominant familial short stature associated with COL11A2 gene variant and the therapeutic response to recombinant human growth hormone.

Journal: Translational pediatrics

Published: December 04, 2024

Monogenic causes of familial short stature.

Journal: Frontiers in endocrinology

Published: October 04, 2024

A rare ACAN non-canonical splicing-site intron variant results in familial short stature.

Journal: Gene

Published: December 20, 2023

Analysis of children with familial short stature: who should be indicated for genetic testing?

Journal: Endocrine connections

Published: June 13, 2023

Analysis of a Chinese pedigree affected with familial short stature due to 15q25.3q26.1 deletion involving the ACAN gene

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

Published: March 27, 2023

Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants.

Journal: Frontiers in pediatrics

Published: November 20, 2021

Response to Letter to the Editor from Youn Hee Jee: "Familial Short Stature - A Novel Phenotype of Growth Plate Collagenopathies".

Journal: The Journal of clinical endocrinology and metabolism

Published: September 02, 2021

NPR2 gene variants in familial short stature: a single-center study.

Journal: Journal of pediatric endocrinology & metabolism : JPEM

Published: May 11, 2021

Definition and prevalence of familial short stature.

Journal: Italian journal of pediatrics

Published: December 12, 2020

Genetic Architecture Associated With Familial Short Stature.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 09, 2019

Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning.

Journal: Journal of biomedical science

Published: May 27, 2019

Filters

The Reassuring and Misleading Myth of Familial Short Stature.

The Reassuring and Misleading Myth of Familial Short Stature.

Two cases of autosomal dominant familial short stature associated with COL11A2 gene variant and the therapeutic response to recombinant human growth hormone.

Two cases of autosomal dominant familial short stature associated with COL11A2 gene variant and the therapeutic response to recombinant human growth hormone.

Monogenic causes of familial short stature.

Monogenic causes of familial short stature.

A rare ACAN non-canonical splicing-site intron variant results in familial short stature.

A rare ACAN non-canonical splicing-site intron variant results in familial short stature.

Analysis of children with familial short stature: who should be indicated for genetic testing?

Analysis of children with familial short stature: who should be indicated for genetic testing?

Analysis of a Chinese pedigree affected with familial short stature due to 15q25.3q26.1 deletion involving the ACAN gene

Analysis of a Chinese pedigree affected with familial short stature due to 15q25.3q26.1 deletion involving the ACAN gene

Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants.

Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants.

Response to Letter to the Editor from Youn Hee Jee: "Familial Short Stature - A Novel Phenotype of Growth Plate Collagenopathies".

Response to Letter to the Editor from Youn Hee Jee: "Familial Short Stature - A Novel Phenotype of Growth Plate Collagenopathies".

NPR2 gene variants in familial short stature: a single-center study.

NPR2 gene variants in familial short stature: a single-center study.

Definition and prevalence of familial short stature.

Definition and prevalence of familial short stature.

Genetic Architecture Associated With Familial Short Stature.

Genetic Architecture Associated With Familial Short Stature.

Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning.

Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning.